-+ 0.00%
-+ 0.00%
-+ 0.00%

Cellectis shareholders vote on plan authorizing up to 4,023,640 stock options

PUBT·06/09/2026 13:34:21
Listen to the news
Cellectis shareholders vote on plan authorizing up to 4,023,640 stock options
  • Shareholders vote June 25, 2026 on authorizing grants of stock options to subscribe for or purchase ordinary shares.
  • Plan capped at 4,023,640 shares, netted against a broader cap covering this plan plus a separate free-share authorization.
  • Executive and senior management awards tied to performance conditions, with vesting starting after three years; unearned portions lapse.
  • Board seeks a 12-month mandate to set grant terms and the subscription or purchase price; statutory auditors raised no objections on pricing methods.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectis SA published the original content used to generate this news brief on June 09, 2026, and is solely responsible for the information contained therein.